Merck CDR (CAD Hedged) (MRK : TSX)
Common Stock
$33.42
CAD
-0.68 (-1.99%)
Last updated: 2026-08-27
Get MRK alerts:
MRK
Merck CDR (CAD Hedged)
WealthAwesomePerformance
1 Day
-1.99%
1 Week
+0.78%
1 Month
+13.56%
YTD
+39.13%
Key Statistics
Market Cap
$296.29B
52W High
$34.90
52W Low
$17.26
P/E Ratio
119.36
50 Day MA
$29.18
200 Day MA
$27.07
Beta
-
Dividend Yield
9.74%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/27/2026 | $33.54 | $33.81 | $33.30 | $33.42 | $33.42 | 3,531 |
| 8/26/2026 | $34.59 | $34.59 | $34.00 | $34.10 | $34.10 | 6,823 |
| 8/25/2026 | $34.03 | $34.90 | $34.00 | $34.86 | $34.86 | 13,809 |
| 8/24/2026 | $33.85 | $33.85 | $33.30 | $33.66 | $33.66 | 6,556 |
| 8/21/2026 | $33.30 | $34.36 | $33.30 | $34.05 | $34.05 | 12,633 |
| 8/20/2026 | $33.64 | $33.95 | $33.16 | $33.16 | $33.16 | 27,285 |
| 8/19/2026 | $32.59 | $34.15 | $32.37 | $33.95 | $33.95 | 43,719 |
| 8/18/2026 | $30.65 | $30.65 | $30.15 | $30.18 | $30.18 | 5,519 |
| 8/17/2026 | $30.30 | $30.33 | $30.29 | $30.33 | $30.33 | 361 |
| 8/14/2026 | $29.94 | $30.24 | $29.90 | $30.24 | $30.24 | 20,857 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRK's historical volatility
30-Day Vol
41.4%
Annualized
90-Day Vol
34.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$39.95
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$35.47 | C$30.75 – C$40.91 |
| 60 trading days | C$37.65 | C$30.76 – C$46.06 |
| 90 trading days | C$39.95 | C$31.20 – C$51.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Merck CDR (CAD Hedged)
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 3690.70%
- EPS (Diluted)
- 0.00
- Book Value
- -
Recent Dividends
$0.1915CAD
Ex: Dec 15, 2025
$0.1848CAD
Ex: Sep 15, 2025
$0.1851CAD
Ex: Jun 16, 2025
$0.1837CAD
Ex: Mar 17, 2025
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MRK
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| PDI | PDI Gold Limited | $4.10 | +336.17% |
| ELR | Eastern Platinum Limited | $0.48 | +37.14% |
| GRC | Gold Springs Resource Corp | $0.07 | +15.38% |
| CJR-B | Corus Entertainment Inc | $0.04 | +14.29% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +12.50% |
| CVVY | Cavvy Energy Ltd. | $2.18 | +12.37% |
| RTG | RTG Mining Inc | $0.05 | +11.11% |
| BB | BlackBerry Ltd | $11.97 | +10.83% |